1Ma Y, Gal A, Koss MN. The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol. 2007;24:150-61.
2Abril A, Cohen MD. Rheumatologic manifestations of sarcoidosis. Curr Opin Rheumatol. 2004;16:51-5.
3Ungprasert P, Crowson CS, Matteson EL. Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study. Arthritis Care Res (Hoboken). 2016;68:695-9.
4Zisman DA, Shorr AF, Lynch JP. Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med. 2002;23:555-70.
5Akasbi N, Abourazzak FZ, Harzy T. Musculoskeletal involvement in sarcoidosis. J Bras Pneumol. 2014;40:175-82.
6Chatham W. Rheumatic manifestations of systemic disease: sarcoidosis. Curr Opin Rheumatol. 2010;22:85-90.
7Sweiss NJ, Patterson K, Sawaqed R, et al. Rheumatologic manifestations of sarcoidosis. Semin Respir Crit Care Med. 2010;31:463-73.
8Kobak S, Sever F, Usluer O, Goksel T, Orman M. The clinical characteristics of sarcoid arthropathy based on a prospective cohort study. Ther Adv Musculoskelet Dis. 2016;8:220-4.
9Reynolds HY: Sarcoidosis: impact of other illnesses on the presentation and management of multiorgan disease. Lung. 2002;180:281-99.
10Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-9.
11Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med. 1974;57:847-52.
12Martins F, Martins M, Malheiro R. Löfgren Syndrome: A Mosaic of Sarcoidosis Phenotypes. Cureus. 2024;16:e52317.
13Patil S, Hilliard CA, Arakane M, et al. Musculoskeletal sarcoidosis: A single center experience over 15 years. Int J Rheum Dis. 2021;24:533-41.
14Ayar K, Ermurat S. Löfgren Sendromunda Kas-iskelet Sistemi Bulgularının Değerlendirildiği Klinik Araştırma. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2020;46:291-7.
15Cacciatore C, Belnou P, Thietart S, et al. Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study. Front Med (Lausanne). 2020;7:565420.
16Arthritis in Sarcoidosis Group (ASG); Agarwal V, Agrawal V, Aggarwal A, et al. Arthritis in sarcoidosis: A multicentric study from India. Int J Rheum Dis. 2018;21:1728-33.
17Torralba K, Quismorio FP Jr. Sarcoid arthritis: a review of clinical features, pathology, and therapy. Sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:95-103.
18Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med. 1983;52:525-33.
19Kobak S. Catch the rainbow: Prognostic factor of sarcoidosis. Lung India. 2020;37:425-32.
20Crowson CS, Matteson EL, Davis JM, et al. Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65:71-7.
21Levitsky A, Brismar K, Hafström I, et al. Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial. RMD Open. 2017;3:e000458.
22Chang X, Yamada R, Sawada T, Suzuki A, Kochi O, Yamamoto K. Citrullination of fibronectin in synovial tissue of rheumatoid arthritis. Rheumatology. 2005;44:1374-82.
23Kobak S, Ylmaz H, Sever F, et al. Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:206-10.
24Fallahi S, Collins RD, Miller RK, Halla JT. Coexistence of rheumatoid arthritis and sarcoidosis: difficulties encountered in the differential diagnosis of common manifestations. J Rheumatol. 1984;11:526-9.
25Sokoloff L, Bunim JJ. Clinical and pathological studies of joint involvement in sarcoidosis. N Engl J Med. 1959;260:841-7.
26Bechman K, Christidis D, Walsh S, et al. A review of the musculoskeletal manifestations of sarcoidosis. Rheumatology. 2018;57:777-83.
27Cadiou S, Robin F, Guillin R, et al. Spondyloarthritis and sarcoidosis: Related or fake friends? A systematic literature review. Joint Bone Spine. 2020;87:579-87.
28Sigaux J, Semerano L, Nasrallah T, et al. High prevalence of spondyloarthritis in sarcoidosis patients with chronic back pain. Semin Arthritis Rheum. 2019;49:246-50.
29Kobak S, Sever F, Ince O, et al. The Prevalence of Sacroiliitis and Spondyloarthritis in Patients with Sarcoidosis. Int J Rheumatol. 2014;2014:289454.
30Erb N, Cushley MJ, Kassimos DG, et al. An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis. Chest. 2005;127:192-6.
31James DG, Neville E, Siltzbach LE. A worldwide review of sarcoidosis. Ann N Y Acad Sci. 1976;278:321-34.
32Sparks JA, McSparron JI, Shah N, et al. Osseous sarcoidosis: clinical characteristics, treatment, and outcomes--experience from a large, academic hospital. Semin Arthritis Rheum. 2014;44:371-9.
33Neville E, Carstairs LS, James DG. Sarcoidosis of bone. Q J Med. 1977;46:215-27.
34Wilcox A, Bharadwaj P, Sharma OP. Bone sarcoidosis. Curr Opin Rheumatol. 2000;12:321-30.
35Moore SL, Teirstein A, Golimbu C. MRI of sarcoidosis patients with musculoskeletal symptoms. Am J Roentgenol. 2005;185:154-9.
36Moore SL, Kransdorf MJ, Schweitzer ME, Murphey MD, Babb JS. Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI? Am J Roentgenol. 2012;198:1387-93.
37Fayad F, Lioté F, Berenbaum F, et al. Muscle involvement in sarcoidosis: a retrospective and followup studies. J Rheumatol. 2006;33:98-103.
38Silverstein A, Siltzbach LE. Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol. 1969;21:235-41.
39Nemoto I, Shimizu T, Fujita Y, et al. Tumour-like muscular sarcoidosis. Clin Exp Dermatol. 2007;32:298-300.
40Ten Dam L, Raaphorst J, Van der Kooi AJ, et al. Clinical characteristics and outcome in muscular sarcoidosis: a retrospective cohort study and literature review. Neuromuscul Disord. 2022;32:557-563.